| Typicality: | 0.376 |
| Saliency: | 0.348 |
| after preliminary clinical evidence | 2 | temporal |
| drug → be intended to treat → serious condition | 18 |
| drug → be intended to treat → serious conditions | 8 |
| drug → be intended to treat → serious disease | 7 |
| drug → be for → serious condition | 5 |
| drug → be used to treat → serious conditions | 3 |
| negative | neutral | positive |
| 0.100 | 0.311 | 0.590 |
| Raw frequency | 41 |
| Normalized frequency | 0.348 |
| Modifier score | 0.700 |
| Perplexity | 14.214 |